Introduction
Undernutrition and chronic inflammation is known to impair linear growth through resistance to GH [1] . Fibroblast growth factor 21 (FGF21); a member of a subfamily of FGFs (including FGF15/19 and FGF23) is considered an important regulator of the metabolic adaptation to fasting, inducing gluconeogenesis, fatty acid oxidation and ketogenesis. The activation FGF21 is highly dependent on the interaction of specific receptors (β-Klotho/ FGFR1 iiiC), forming a complex with FGF21 on the cell surface [2] . Recent studies have shown that elevated expression of FGF21, secondary to prolonged undernutrition develops GH resistance and subsequent attenuation of skeletal growth and growth plate chondrogenesis in both mice and human (Fig.1) • Assessment of GHR signaling.
• Expression of FGF21 receptor complex in vitro and in vivo.
Validation of the GHR model
• Determine the role of FGF21 on GHR half-life.
• Examine the affect of FGF21 on JAK/STAT signaling and negative feedback regulation SOCS2. 
The role of FGF21 in GH resistance

Validation of the GHR model
• Generated the tools to study GH/GHR signaling in stable cell lines and chondrocyte cell lines.
• Growth hormone potentiates the activation of down-stream signaling in the JAK/STAT5 pathway.
The proposed mechanism of FGF21 in GH resistance
• Chronic exposure to FGF21 reduces GHR half-life and inhibits early upstream mediators (pSTAT5) in GHR signaling.
• Chronic exposure to FGF21 increases SOCS2 expression. Growth
